Jen-Fu Yang

425 total citations
20 papers, 277 citations indexed

About

Jen-Fu Yang is a scholar working on Surgery, Hepatology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jen-Fu Yang has authored 20 papers receiving a total of 277 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Surgery, 9 papers in Hepatology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jen-Fu Yang's work include Hepatocellular Carcinoma Treatment and Prognosis (9 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers) and Radiomics and Machine Learning in Medical Imaging (5 papers). Jen-Fu Yang is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (9 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers) and Radiomics and Machine Learning in Medical Imaging (5 papers). Jen-Fu Yang collaborates with scholars based in Taiwan, United Kingdom and United States. Jen-Fu Yang's co-authors include Wen‐Yen Huang, Cheng‐Hsiang Lo, Chun‐Shu Lin, Meei‐Shyuan Lee, Hsing‐Lung Chao, Wei‐Chou Chang, Yee‐Min Jen, Yu–Fu Su, Chang‐Chieh Wu and Kuen‐Tze Lin and has published in prestigious journals such as PLoS ONE, Scientific Reports and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Jen-Fu Yang

19 papers receiving 274 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jen-Fu Yang Taiwan	11	155	86	74	73	60	20	277
Ermanno Notarianni Italy	6	153 1.0×	99 1.2×	86 1.2×	74 1.0×	63 1.1×	16	250
Hee Rim Nam South Korea	7	149 1.0×	97 1.1×	35 0.5×	104 1.4×	66 1.1×	14	336
Denise N. Gansen United States	7	138 0.9×	66 0.8×	67 0.9×	51 0.7×	49 0.8×	8	272
A Little Australia	8	191 1.2×	99 1.2×	99 1.3×	121 1.7×	61 1.0×	12	347
P Hilgard Germany	5	220 1.4×	73 0.8×	72 1.0×	75 1.0×	47 0.8×	6	309
Jennifer A. Shannon Australia	5	196 1.3×	124 1.4×	150 2.0×	119 1.6×	53 0.9×	10	317
Sonia Sahu United States	13	149 1.0×	74 0.9×	101 1.4×	56 0.8×	133 2.2×	16	318
Issa Mohamad Jordan	8	47 0.3×	78 0.9×	66 0.9×	41 0.6×	66 1.1×	45	243
Joong-Won Park South Korea	6	190 1.2×	60 0.7×	65 0.9×	46 0.6×	98 1.6×	8	301
Woo Jin Lee South Korea	6	292 1.9×	116 1.3×	114 1.5×	121 1.7×	141 2.4×	8	455

Countries citing papers authored by Jen-Fu Yang

Since Specialization

Citations

This map shows the geographic impact of Jen-Fu Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jen-Fu Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jen-Fu Yang more than expected).

Fields of papers citing papers by Jen-Fu Yang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jen-Fu Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jen-Fu Yang. The network helps show where Jen-Fu Yang may publish in the future.

Co-authorship network of co-authors of Jen-Fu Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Jen-Fu Yang. A scholar is included among the top collaborators of Jen-Fu Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jen-Fu Yang. Jen-Fu Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Po‐Huang, Cheng‐Hsiang Lo, Yu–Fu Su, et al.. (2025). Radiation dose escalation in locally advanced oesophageal cancer: a systematic review and hierarchical Bayesian meta-analysis. EClinicalMedicine. 87. 103432–103432.

Lo, Cheng‐Hsiang, Yu–Fu Su, Jen-Fu Yang, et al.. (2024). Identification of a Suitable Subgroup for Radiation Dose Escalation in Definitive Concurrent Chemoradiation Therapy for Nonmetastatic Esophageal Squamous Cell Carcinoma. JCO Precision Oncology. 8(8). e2400555–e2400555. 1 indexed citations

Huang, Wen‐Yen, et al.. (2022). Developing a novel DNA methylation risk score for survival and identification of prognostic gene mutations in endometrial cancer: a study based on TCGA data. Japanese Journal of Clinical Oncology. 52(9). 992–1000. 3 indexed citations

Yang, Jen-Fu, Yu‐Ling Tsai, Wen‐Chiuan Tsai, et al.. (2022). Guggulsterone inhibits migration and invasion through proteasomal and lysosomal degradation in human glioblastoma cells. European Journal of Pharmacology. 938. 175411–175411. 4 indexed citations

Yang, Jen-Fu, Wen‐Yen Huang, Cheng‐Hsiang Lo, et al.. (2022). Significant muscle loss after stereotactic body radiotherapy predicts worse survival in patients with hepatocellular carcinoma. Scientific Reports. 12(1). 19100–19100. 4 indexed citations

Huang, Wen‐Yen, Cheng‐Hsiang Lo, Jen-Fu Yang, et al.. (2022). Radiomics-Based Predictive Model of Radiation-Induced Liver Disease in Hepatocellular Carcinoma Patients Receiving Stereo-Tactic Body Radiotherapy. Biomedicines. 10(3). 597–597. 11 indexed citations

Lin, Chun‐Shu, et al.. (2021). Clinical outcome and pathologic correlation of stereotactic body radiation therapy as a bridge to transplantation for advanced hepatocellular carcinoma: a case series. Radiation Oncology. 16(1). 13 indexed citations

Huang, Wen‐Yen, et al.. (2021). Dynamic Changes in Neutrophil-to-Lymphocyte Ratio are Associated with Survival and Liver Toxicity Following Stereotactic Body Radiotherapy for Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma. Volume 8. 1299–1309. 10 indexed citations

Lo, Cheng‐Hsiang, et al.. (2021). Radiosensitivity index emerges as a potential biomarker for combined radiotherapy and immunotherapy. npj Genomic Medicine. 6(1). 40–40. 27 indexed citations

10.

Lo, Cheng‐Hsiang, et al.. (2021). Gene-associated methylation status of ST14 as a predictor of survival and hormone receptor positivity in breast Cancer. BMC Cancer. 21(1). 945–945. 5 indexed citations

11.

Chang, Wei‐Chou, Cheng‐Hsiang Lo, Jen-Fu Yang, et al.. (2021). Using computed tomography-based radiomics to predict outcomes for hepatocellular carcinoma patients receiving stereotactic body radiotherapy. 5. 13–13. 1 indexed citations

12.

Yang, Jen-Fu, Cheng‐Hsiang Lo, Meei‐Shyuan Lee, et al.. (2019). Stereotactic ablative radiotherapy versus conventionally fractionated radiotherapy in the treatment of hepatocellular carcinoma with portal vein invasion: a retrospective analysis. Radiation Oncology. 14(1). 180–180. 27 indexed citations

13.

Chang, Wei‐Chou, Cheng‐Hsiang Lo, Jen-Fu Yang, et al.. (2019). Comparison of Stereotactic Body Radiation Therapy and Transarterial Chemoembolization for Unresectable Medium-Sized Hepatocellular Carcinoma. International Journal of Radiation Oncology*Biology*Physics. 105(2). 307–318. 58 indexed citations

14.

Lo, Cheng‐Hsiang, Wen‐Yen Huang, Meei‐Shyuan Lee, et al.. (2019). Prognostic Significance of Apparent Diffusion Coefficient in Hepatocellular Carcinoma Patients treated with Stereotactic Ablative Radiotherapy. Scientific Reports. 9(1). 14157–14157. 13 indexed citations

15.

Lo, Cheng‐Hsiang, Jen-Fu Yang, Yee‐Min Jen, et al.. (2017). Survival and prognostic factors for patients with advanced hepatocellular carcinoma after stereotactic ablative radiotherapy. PLoS ONE. 12(5). e0177793–e0177793. 21 indexed citations

16.

Huang, Wen‐Yen, Kuen‐Tze Lin, Chun‐Shu Lin, et al.. (2017). Lower Urinary Tract Infection and Subsequent Risk of Prostate Cancer: A Nationwide Population-Based Cohort Study. PLoS ONE. 12(1). e0168254–e0168254. 9 indexed citations

17.

Lo, Cheng‐Hsiang, Meei‐Shyuan Lee, Jen-Fu Yang, et al.. (2017). Comparison Between Child-Turcotte-Pugh and Albumin-Bilirubin Scores in Assessing the Prognosis of Hepatocellular Carcinoma After Stereotactic Ablative Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 99(1). 145–152. 31 indexed citations

18.

Huang, Wen‐Yen, Ching‐Liang Ho, Chia‐Cheng Lee, et al.. (2017). Oral tegafur-uracil as metronomic therapy following intravenous FOLFOX for stage III colon cancer. PLoS ONE. 12(3). e0174280–e0174280. 19 indexed citations

19.

Lo, Cheng‐Hsiang, Chun‐Shu Lin, Hsing‐Lung Chao, et al.. (2017). Stereotactic Ablative Radiotherapy for Patients with Unresectable or Medically Inoperable Cholangiocarcinoma. Tumori Journal. 103(3). 236–241. 8 indexed citations

20.

Yang, Jen-Fu, Meei‐Shyuan Lee, Chun‐Shu Lin, et al.. (2016). Long-Term Breast Cancer Patient Outcomes After Adjuvant Radiotherapy Using Intensity-Modulated Radiotherapy or Conventional Tangential Radiotherapy. Medicine. 95(11). e3113–e3113. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact